Federal Register / Vol. 72, No. 233 / Wednesday, December 5, 2007 / Notices 68591 

Name of Committee: Literature Selection 

Technical Review Committee. 

Date: February 28–29, 2008. 

Open: February 28, 2008, 9 a.m. to 11 a.m. 

Agenda: Administrative reports and 

program discussion. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20894. 

Closed: February 28, 2008, 11 a.m. to 5 

p.m. 

Agenda: To review and evaluate journals 

as potential titles to be indexed by the 

National Library of Medicine. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20894. 

Closed: February 29, 2008, 8:30 a.m. to 2 

p.m. 

Agenda: To review and evaluate journals 

as potential titles to be indexed by the 

National Library of Medicine. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20894. 

Contact Person: Sheldon Kotzin, MLS, 

Associate Director, Division of Library 

Operations, National Library of Medicine, 

8600 Rockville Pike, Bldg. 38/Room 2W06, 

Bethesda, MD 20894, 301–496–6921, 

Sheldon_Kotzin@nlm.nih.gov. 

Any interested person may file written 

comments with the Committee by forwarding 

the statement to the Contact Person listed on 

this Notice. The statement should include the 

name, address, telephone number and, when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

into the building by non-government 

employees. Persons without a government 

I.D. will need to show a photo I.D. and sign 

in at the security desk upon entering the 

building. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS) 

Dated: November 27, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy, NIH. 

[FR Doc. 07–5929 Filed 12–04–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C., Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Kidney 

Monitoring and Therapeutics Small Business 

Review. 

Date: December 18, 2007. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Krystyna E. Rys-Sikora, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4016J, 

MSC 7814, Bethesda, MD 20892, 301–451–

1325, ryssokok@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Hematopoietic Stem Cells. 

Date: December 20, 2007. 

Time: 11 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Delia Tang, MD, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 4126, MSC 7802, 

Bethesda, MD 20892, 301–435–2506, 

tangd@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Nanotechnology in Heart, Lung and Blood. 

Date: January 16–17, 2008. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Alexandra M. Ainsztein, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5144, 

MSC 7840, Bethesda, MD 20892, 301–451–

3848, ainsztea@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: November 28, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5926 Filed 12–4–07; 8:45 am] 

BILLING CODE 4140–01–M 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 332–493] 

Advice Concerning Possible 

Modifications to the U.S. Generalized 

System of Preferences, 2007 Review of 

Additions and Removals 

AGENCY: United States International 

Trade Commission. 

ACTION: Change in scope of 

investigation. 

SUMMARY: Following receipt of a letter 

on November 26, 2007, from the United 

States Trade Representative (USTR) 

advising of the withdrawal of petitions 

requesting the addition of the following 

three articles to the list of articles 

eligible for duty-free treatment under 

the Generalized System of Preferences 

(GSP) program, the Commission has 

terminated its investigation with respect 

to those three articles and will not 

provide probable economic effect advice 

with respect to those articles: 

Molybdenum ores and concentrates, 

roasted (HTS subheading 2613.10.00, 

USTR accepted case 2007–01); 

Molybdenum ores and concentrates, 

other (HTS subheading 2613.90.00, 

USTR accepted case 2007–02); and 

Other synthetic organic pigments and 

coloring preparations (HTS subheading 

3204.17.90, USTR accepted case 2007–

04). 

The Commission expects to transmit 

its report to the USTR providing its 

advice with respect to the remaining 

articles that are the subject of the 

USTR’s request for advice by December 

19, 2007. 

ADDRESSES: All Commission offices, 

including the Commission’s hearing 

rooms, are located in the United States 

International Trade Commission 

Building, 500 E Street, SW., 

Washington, DC. All written 

submissions should be addressed to the 

Secretary, United States International 

Trade Commission, 500 E Street, SW., 

Washington, DC 20436. The public 

record for this investigation may be 

viewed on the Commission’s electronic 

docket (EDIS) at http://www.usitc.gov/ 

secretary/edis.htm. 

FOR FURTHER INFORMATION CONTACT: 

Information may be obtained from 

Cynthia B. Foreso, Project Leader, Office 

mstockstill on PROD1PC66 with NOTICES